United Services Automobile Association Revance Therapeutics, Inc. Transaction History

United Services Automobile Association

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$10.22 - $14.5 $846,849 - $1.2 Million	-82,862 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$10.67 - $15.49 $7,735 - $11,230	725 Added 0.88%	82,862 $1.08 Million
Q1 2019 May 13, 2019	BUY	$15.4 - $20.39 $138,600 - $183,510	9,000 Added 12.31%	82,137 $1.29 Million
Q4 2018 Feb 13, 2019	SELL	$18.06 - $24.96 $93,009 - $128,544	-5,150 Reduced 6.58%	73,137 $1.47 Million
Q3 2018 Nov 13, 2018	SELL	$23.55 - $30.1 $26,611 - $34,013	-1,130 Reduced 1.42%	78,287 $1.95 Million
Q2 2018 Aug 10, 2018	SELL	$27.45 - $33.35 $14,877 - $18,075	-542 Reduced 0.68%	79,417 $2.18 Million
Q1 2018 May 14, 2018	BUY	$29.15 - $37.4 $40,780 - $52,322	1,399 Added 1.78%	79,959 $2.46 Million
Q4 2017 Feb 14, 2018	BUY	$24.55 - $36.3 $481,032 - $711,262	19,594 Added 33.23%	78,560 $2.81 Million
Q3 2017 Nov 14, 2017	BUY	$22.55 - $28.1 $1.33 Million - $1.66 Million	58,966	58,966 $1.63 Million

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.